retatrutide trial dosing ESC 2024: improves lipid and cardiovascular risk profile in Phase II Retatrutide Dosing Schedule: Proven 2026

Statins remain the gold-standard first-line treatment for elevated LDL cholesterol, capable of reducing LDL levels by 3050% depending on dose and agent

Do not stop your medication without consulting your doctor

GLP-1 ,

The pancreas and liver make more insulin when they need to and less glucagon when they don't

Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type2diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X)

MedVi has LegitScript certification as a pharmacy and telemedicine website MedVi is LegitScript-certified, which means it meets recognized standards for safety, legality and transparency in telemedicine